BML 190
| CAS No. | 2854-32-2 | Cat. No. | BCP02700 |
| Name | BML 190 | ||
| Synonyms | BML-190;BML190; LM-4131; LM4131; LM 4131; IMMA; Indomethacin Morpholinylamide; | ||
| Formula | C23H23ClN2O4 | M. Wt | 426.89 |
| Description | BML-190 has 50-fold selectivity for CB2 receptors over CB1 receptors. In HEK-293 cells stably expressing the human CB2 receptor, BML-190 potentiates the forskolin-stimulated accumulation of cAMP. BML-190 reduces the basal levels of inositol phosphate production in cells expressing the CB2 receptor. 10 μM of BML-190 decreases inositol phosphates accumulation by 38%.BML-190 is an aminoalkylindole. BML-190 is found to yield at least 15 metabolic products.BML-190 diminishes LPS-induced NO and IL-6 production in a concentration-dependent manner. BML-190 also inhibits LPS-induced PGE2 production and COX-2 induction. | ||
| Pathways | GPCR/G Protein | ||
| Targets | Cannabinoid Receptor | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.